Ex parte KANE - Page 3




              Appeal No. 1996-2769                                                                                      
              Application 08/270,089                                                                                    


                     The appellant’s invention is directed to a method of making improved phosphors                     
              having a uniform, spherical shape and particle size below one micron.  According to the                   
              specification                                                                                             
                            Phosphors typically comprise one or more rare earth metals in a host                        
                     material.  Up-converter phosphors emit light in the visible wavelength radiation                   
                     range (550-800 nanometers) when excited by long wavelength radiation, e.g., light                  
                     in the infrared wavelength spectrum. This is accomplished by multiple absorption of                
                     infrared photons and energy transfer between the absorbing and the emitting ions.                  
                     For example, it is known that yttrium oxysulfide, Y O S, gadolinium oxysulfide,                    
                                                                        2  2                                            
                     Gd O S, and lanthanum oxysulfide La O S, doped with certain activator couples, will2 2                               2  2                                                        
                     be excited by 0.96 micron wavelength radiation.  Such radiation can be provided by                 
                     semiconductor lasers [specification , p. 1].                                                       
                     The phosphors of the present invention are said to be useful in biological assays for              
              detecting compounds such as proteins, drugs, and polynucleotides.  Specification, p. 1.                   
              The specification indicates that the phosphors “can be used as immunoassay labels by                      
              attaching them to one or more probes, such as antibodies, protein A, polypeptide ligands                  
              of cellular receptors, polynucleotides, drugs, antigens, toxins and the like.”  Id., p. 2.                

                     The examiner’s findings of fact and conclusion(s) of obviousness were set forth in                 
              the Answer as follows.  The examiner first applied Royce, a patent which was said to                      
              disclose a process of heating a “mixture of rare earth oxides and a flux of sulfur and at                 
              least one alkali metal salt at a temperature of 700-1250EC in the absence of oxygen,” as                  
              the primary reference.  Answer, p. 4.  The examiner acknowledged that Royce did not                       
              teach “the specifically claimed oxysulfide nor the claimed activator couples because they                 


                                                           3                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007